A recent analysis of the return on investment for NIH-supported research has highlighted a strong disproportion between the amount of money allocated on research and the actual benefits to the U.S. population.
Physicians Committee scientists are working to prove that antibodies can be made without harming animals. Our goal is to demonstrate the viability of fully in vitro antibodies, promote their acceptance by researchers, and force a change in the funding requirements of the National Institutes of Health.
A new commentary in the Journal of Alzheimer’s Disease by Physicians Committee medical research specialist Francesca Pistollato, Ph.D., and colleagues, addresses the need to refocus current research efforts on human-based methods, such as human cells and computational models, together with epidemiological and clinical studies. These tools will help facilitate human-relevant data acquisition, in an effort to face the increasing prevalence of Alzheimer’s disease.
Human immune cells may be a new alternative to animals for evaluating new vaccine candidates, according to a study published in ALTEX.
Primary human cells can be used in place of animals to test environmental and industrial chemicals, according to a new paper published in Nature Biotechnology.
One of the most ill-understood and overwhelming diseases is in dire need of new research and prevention strategies, according to a new scientific paper published in the journal ALTEX.